Your browser is no longer supported. Please, upgrade your browser.
ABT Abbott Laboratories daily Stock Chart
Abbott Laboratories
IndexS&P 500 P/E62.47 EPS (ttm)0.72 Insider Own0.70% Shs Outstand1.73B Perf Week-1.02%
Market Cap77.36B Forward P/E16.26 EPS next Y2.75 Insider Trans1.80% Shs Float1.72B Perf Month-1.48%
Income1.06B PEG5.56 EPS next Q0.43 Inst Own65.10% Short Float0.77% Perf Quarter17.73%
Sales20.85B P/S3.71 EPS this Y-58.60% Inst Trans1.70% Short Ratio1.53 Perf Half Y7.31%
Book/sh13.89 P/B3.22 EPS next Y12.19% ROA3.30% Target Price47.85 Perf Year12.55%
Cash/sh10.86 P/C4.12 EPS next 5Y11.24% ROE6.80% 52W Range36.07 - 45.84 Perf YTD17.21%
Dividend1.06 P/FCF142.47 EPS past 5Y0.00% ROI6.70% 52W High-2.42% Beta1.41
Dividend %2.37% Quick Ratio3.70 Sales past 5Y-0.50% Gross Margin56.80% 52W Low24.00% ATR0.55
Employees75000 Current Ratio4.00 Sales Q/Q2.80% Oper. Margin15.30% RSI (14)54.05 Volatility1.15% 1.12%
OptionableYes Debt/Eq1.05 EPS Q/Q11.00% Profit Margin6.70% Rel Volume0.55 Prev Close44.77
ShortableYes LT Debt/Eq1.01 EarningsApr 26 BMO Payout109.70% Avg Volume8.68M Price44.73
Recom1.90 SMA20-1.12% SMA502.98% SMA2008.66% Volume4,753,063 Change-0.09%
Mar-01-17Reiterated RBC Capital Mkts Outperform $46 → $50
Jan-26-17Reiterated RBC Capital Mkts Outperform $48 → $46
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-24-17 05:25PM  Micron, SeaWorld and HCA jump while GameStop plunges
04:15PM  Mylan Topples After Big Med Player Divests 63% Of Its Shares
03:28PM  Abbott Sells More Mylan Holdings
11:41AM  Mylan Hit After Abbott Dumps Shares
11:18AM  [video]Can the Repeal of the Fiduciary Rule Harm Your Annuities Investments?
Mar-22-17 05:56PM  MedTech Long-Term Prospects Impress: Which Stocks to Buy?
02:47PM  ABBOTT LABORATORIES Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balan
02:47PM  Can Abbott Outperform Despite Alere?
09:00AM  Abbott Hosts Conference Call for First-Quarter Earnings PR Newswire
Mar-20-17 09:37AM  Abbott Labs Is Set to Go Substantially Higher
09:14AM  Abbott Laboratories' MitraClip Outcome Positive for DMR
Mar-19-17 02:00PM  Late-Breaking Data Shows the CardioMEMS HF System is Effective in Reducing Heart Failure Hospitalizations and Cost of Care PR Newswire
Mar-18-17 12:30PM  Late-Breaking Data on Abbott's MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease PR Newswire
Mar-16-17 11:51AM  Alere Delays Filing for 2nd Year in a Row
09:52AM  How to Get Diabetics Addicted to Data
08:05AM  Life-Saving Device Could Transform The Medical Market In 2017
Mar-15-17 11:34AM  Dealpolitik: Abbott Vs. Alere: A Case for Revising the MAE at The Wall Street Journal
08:00AM  GDS Investments Shares Bullish Theses on FMC, GM, Mosaic, More at Insider Monkey
07:36AM  Johnson & Johnsons Major Developments
Mar-14-17 06:07PM  Abbott Laboratories Downgraded by MBO
12:25PM  ABBOTT LABORATORIES Files SEC form 8-K, Change in Directors or Principal Officers
12:08PM  BMO On Abbott Labs: 'It's Likely Time For The Stock To Take A Pause'
08:42AM  Abbott Laboratories Stock Downgraded by BMO
Mar-13-17 08:01AM  The Next Big Biotech Breakthrough Could Just Be On The Horizon
Mar-10-17 03:05PM  Former Angels star faces federal insider trading charges at
Mar-08-17 05:15PM  AbbVie Is a Screaming Dividend Growth Buy... Here's Why
04:15PM  Abbott to Present at Barclays Capital 2017 Global Healthcare Conference PR Newswire
09:00AM  New Study Results May Lead to a New Standard of Care for In Vitro Fertilization Treatment PR Newswire
Mar-07-17 10:05AM  AAA Credit Rating Stocks in Focus: Johnson & Johnson
09:00AM  Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture PR Newswire
07:43AM  Carson Block's short seller's strategy
Mar-03-17 02:21PM  Abbott Laboratories : ABT-US: Dividend Analysis : January 13th, 2017 (record date) : By the numbers : March 3, 2017
Mar-01-17 02:15PM  Alere delays annual filing for second year in a row at
01:42PM  Alere's Bad News Tests the Limits of Patience
09:15AM  Top Analysts Upgrades and Downgrades: Abbott Labs, General Dynamics, Nexstar Media, Owens Corning, Palo Alto Networks, Salesforce and More
06:59AM  Diagnostic company Alere says to delay filing annual report Reuters
Feb-28-17 09:07AM  Strong Performance of AstraZenecas Brilinta and Farxiga in 2016
07:36AM  Pfizers Profitability and Financial Guidance
Feb-27-17 03:06AM  Abbott Labs (ABT) Up 10.8% Since Earnings Report: Can It Continue?
Feb-24-17 07:39AM  Performance of Eli Lilly & Co.s Business Segments in 4Q16
Feb-23-17 05:08PM  2 Dividend Aristocrats Trading At A Discount
04:47PM  Abbott Laboratories -- Moody's assigns Baa3 to Abbott's proposed exchange notes at Moody's
01:52PM  FTC Settles Charges of Anti-Competition in Abbot, St. Jude Deal
Feb-22-17 05:58PM  Abbott Laboratories Declares Quarterly Dividend
01:01PM  EU mergers and takeovers (Feb 22) Reuters
Feb-21-17 08:55AM  Abbott Commences Exchange Offers and Consent Solicitations for St. Jude Medical, LLC Notes PR Newswire
08:26AM  ABBOTT LABORATORIES Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements an
Feb-17-17 04:05PM  ABBOTT LABORATORIES Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial St
11:25AM  Abbott Declares 373rd Consecutive Quarterly Dividend PR Newswire
Feb-15-17 08:30AM  Real-World Data from Abbott's FreeStyle® Libre Show Association Between Higher Frequency of Glucose Monitoring and Improved Glucose Control for People with Diabetes PR Newswire
Feb-14-17 05:40PM  Dysfunction, Heartbreak And Love: 11 Most Interesting Corporate Couples
Feb-12-17 03:09PM  Abbott Laboratories may see boost from St. Jude's acquisition: Barron's
10:29AM  5 Trade Ideas for Monday: Abbott Labs, ARRIS, BorgWarner, Lockheed and Nasdaq
Feb-11-17 12:01AM  [$$] Prognosis on Abbott Labs' Stock: 20% Return at
Feb-08-17 01:23PM  High-Powered Insiders Are Buying These 5 Stocks; Should You?
Feb-07-17 03:58PM  Dept. of Homeland Security Provides A Timely Update On Abbott, St. Jude
Feb-06-17 01:30PM  Locust Wood Boosts Exposure to These Companies at Insider Monkey
Feb-04-17 01:16AM  Insider Buys Highlight for Week of Jan. 30
Feb-03-17 11:36PM  [$$] Robert Schoellhorn Found New Career After Serving as Abbott Labs CEO at The Wall Street Journal
10:52AM  Abbott Laboratories (ABT)s Molecular Test For Detecting Zika Virus Approved By The FDA at Insider Monkey
05:30AM  [$$] Robert Schoellhorn Found New Career After Serving as Abbott Labs CEO at The Wall Street Journal
Feb-02-17 04:09PM  No "Sophomore Slump" Ahead For Boston Scientific at
12:13PM  ETFs with exposure to Abbott Laboratories : February 2, 2017
12:01PM  Abbott Laboratories (ABT) Pacemakers Get FDA Approval at Insider Monkey
11:53AM  FDA Approves Abbott Labs' Devices for MRI Scans
11:22AM  Edwards Lifesciences Sinks 9%; Is This A Buying Opportunity? at
08:00AM  U.S. FDA Grants Abbott the First Commercial Authorization for a Molecular Test to Detect Zika Virus Using Whole Blood PR Newswire
Feb-01-17 08:00AM  Abbott Announces U.S. Approval for its Assurity MRI Pacemaker, the World's Smallest, Longest-Lasting Wireless MRI-Compatible Pacemaker PR Newswire
Jan-30-17 07:36AM  Johnson & Johnsons 4Q16 Earnings: Major Developments
Jan-27-17 11:52AM  AbbVie Reports 4th-Quarter 2016 Results
Jan-26-17 01:35PM  Changes in Johnson & Johnsons Growth Rate in 4Q16
11:47AM  J&J to spend $30 billion on Swiss drugmaker Actelion
11:36AM  Q4 Scorecard and Analyst Reports for Texas Instruments & Lockheed Martin
10:21AM  Abbott Laboratories :ABT-US: Earnings Analysis: Q4, 2016 By the Numbers : January 26, 2017
06:46AM  Wall Street's M&A Chatter From January 25
Jan-25-17 06:08PM  Abbott Laboratories Gains Despite Unimpressive Q4 Revenue Results
05:18PM  Abbott Laboratories Releases 4th-Quarter Results
12:23PM  Abbott tops 4Q profit forecasts, falls short on revenue
12:17PM  Abbott pauses on deals, to focus on St. Jude integration
12:12PM  EU mergers and takeovers (Jan 25) Reuters
11:18AM  Edited Transcript of ABT earnings conference call or presentation 25-Jan-17 2:00pm GMT
11:00AM  Abbott Labs (ABT) Tops Q4 Earnings Estimates, Sales In Line
11:00AM  European Commission Clears Abbott Acquisition of Alere PR Newswire
10:55AM  Siemens to pick banks for Healthineers listing - sources Reuters
10:15AM  EU clears Abbott acquisition of Alere subject to divestments Reuters
09:37AM  Abbott Laboratories (ABT): Tops Q4 Earnings, Sales in Line
09:13AM  Nutrition unit, strong dollar weigh on Abbott's sales
09:08AM  [$$] Abbott Labs Profit Rises, But Nutrition Business Struggles at The Wall Street Journal
09:00AM  Abbott Laboratories Earnings Call scheduled for 9:00 am ET today
08:58AM  Abbott Shares Dip on Mixed Fourth-Quarter Earnings
08:02AM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
07:56AM  Abbott Labs' sales rise 2.8 pct
07:45AM  Abbott Reports Fourth-Quarter 2016 Results PR Newswire
07:37AM  Market Recon: The President's Actions Renew Belief in the Agenda
07:07AM  Q4 2016 Abbott Laboratories Earnings Release - Before Market Open
05:21AM  Futures point to a higher open on Wall Street, slew of earnings eyed at CNBC
Jan-24-17 12:45PM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
Jan-23-17 04:54PM  The Best Health Care REITs for 2017
10:36AM  Whats New with Johnson & Johnson?
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YOOR BRIAN BExecutive Vice President & CFOMar 01Sale45.391,72878,43463,425Mar 02 05:19 PM
NATH DEEPAK S.Senior Vice PresidentMar 01Sale45.391,60172,66951,430Mar 02 05:17 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentMar 01Sale45.392,06693,77672,112Mar 02 05:16 PM
Watkin JaredSenior Vice PresidentMar 01Sale45.3997044,02848,511Mar 02 05:12 PM
Warmuth Michael JExecutive Vice PresidentMar 01Sale45.393,851174,79756,508Mar 02 05:04 PM
MANNING JOSEPH JSenior Vice PresidentFeb 28Sale44.9674433,45323,024Mar 02 05:18 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 28Sale45.0185738,569100,879Mar 02 05:15 PM
BIRD ROGERSenior Vice PresidentFeb 28Sale45.021,60172,06956,913Mar 02 05:11 PM
Mason Heather LExecutive Vice PresidentFeb 28Sale45.011,91286,06859,677Mar 02 05:06 PM
Contreras JaimeSenior Vice PresidentFeb 28Sale45.0113,155592,15745,733Mar 02 05:05 PM
Funck Robert EVice President, ControllerFeb 23Option Exercise26.7025,500680,781117,579Feb 24 05:28 PM
Funck Robert EVice President, ControllerFeb 23Sale45.5025,5001,160,25092,079Feb 24 05:28 PM
BIRD ROGERSenior Vice PresidentFeb 22Option Exercise26.6212,903343,53975,767Feb 22 05:59 PM
BIRD ROGERSenior Vice PresidentFeb 22Sale45.0212,903580,93862,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Option Exercise26.7093,4002,493,528382,197Feb 22 05:57 PM
MANNING JOSEPH JSenior Vice PresidentFeb 21Sale44.981466,56720,146Feb 22 06:18 PM
BIRD ROGERSenior Vice PresidentFeb 21Sale44.9431914,33562,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Sale45.0093,4004,203,000288,797Feb 22 05:57 PM
Watkin JaredSenior Vice PresidentFeb 21Sale44.9855524,96551,977Feb 22 05:57 PM
NATH DEEPAK S.Senior Vice PresidentFeb 21Sale44.9831914,34957,333Feb 22 05:34 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Option Exercise25.253,40085,83791,857Feb 15 05:04 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Sale43.003,400146,20088,457Feb 15 05:04 PM
MANNING JOSEPH JSenior Vice PresidentFeb 03Option Exercise25.253007,57420,792Feb 07 05:02 PM
Mason Heather LExecutive Vice PresidentJan 31Option Exercise25.2535,700901,286100,189Feb 02 05:31 PM
Fussell Stephen RExecutive Vice PresidentJan 31Buy40.7712,200497,394167,167Feb 02 05:32 PM
Mason Heather LExecutive Vice PresidentJan 31Sale40.7735,7001,455,48964,489Feb 02 05:31 PM
Blaser Brian JExecutive Vice PresidentDec 20Buy38.4515,580599,120145,062Dec 21 02:19 PM
Ford Robert BExecutive Vice PresidentDec 14Buy39.0912,775499,34569,542Dec 16 05:07 PM
CAPEK JOHN MExecutive Vice PresidentNov 16Option Exercise24.3822,000536,386274,524Nov 18 05:02 PM
WHITE MILES DChairman and CEONov 10Buy40.6758,2632,369,4483,111,967Nov 14 10:04 AM
WHITE MILES DChairman and CEONov 10Buy40.5389,5783,630,2943,004,943Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.6548,7611,982,0793,053,704Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.5451,8922,103,4552,793,909Nov 14 10:02 AM
WHITE MILES DChairman and CEONov 10Buy40.45121,4564,912,7412,915,365Nov 14 10:02 AM
Blount Sally E.DirectorNov 01Buy39.245,100200,12420,143Nov 02 05:12 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale41.7181533,99458,976Sep 28 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 29Option Exercise25.2556,0001,413,782438,682Jul 29 05:04 PM
Fussell Stephen RExecutive Vice PresidentJul 28Option Exercise25.2541,5001,047,713196,467Jul 29 05:03 PM
Fussell Stephen RExecutive Vice PresidentJul 28Sale45.0041,5001,867,640154,967Jul 29 05:03 PM
Warmuth Michael JExecutive Vice PresidentJul 26Option Exercise25.2526,800676,59581,811Jul 27 04:43 PM
Warmuth Michael JExecutive Vice PresidentJul 26Sale43.4926,8001,165,45755,011Jul 27 04:43 PM
WHITE MILES DChairman and CEOJul 25Option Exercise25.25550,00013,885,3552,010,517Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Option Exercise25.2526,800676,595111,819Jul 27 04:44 PM
WHITE MILES DChairman and CEOJul 25Buy43.3417,933777,1622,742,017Jul 27 04:31 PM
WHITE MILES DChairman and CEOJul 25Buy43.26176,8047,648,8232,724,084Jul 27 04:30 PM
WHITE MILES DChairman and CEOJul 25Buy43.19181,2637,828,6282,434,327Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.34112,9534,895,2172,547,280Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.18242,54710,472,9392,253,064Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Sale43.0826,8001,154,54485,019Jul 27 04:44 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Option Exercise20.753,40070,54591,857Jun 30 05:58 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Sale37.143,400126,27688,457Jun 30 05:58 PM
Watkin JaredSenior Vice PresidentJun 15Sale37.6355220,77046,562Jun 17 05:05 PM
YOOR BRIAN BSenior Vice President and CFOJun 01Sale39.4956522,31249,617Jun 03 05:10 PM
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM
Contreras JaimeSenior Vice PresidentMar 31Sale41.7846219,3042,426Apr 01 05:01 PM